Randomized study to compare vaginal misoprostol to oral misoprostol in inducing labor

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2015-001972-23-FI

Enrollment

300

Registered

2015-06-29

Start date

2015-06-29

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant women

Interventions

Trade Name: Misodel Product Name: Misodel Product Code: G02AD06 Pharmaceutical Form: Vaginal delivery system Trade Name: Cytotec Product Name: Cytotec Product Code: A02BB01 Pharmaceutical Form: Table

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 200 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: Efficacy of vaginal Misodel compared to standard oral use of Cytotec;Secondary Objective: Safety issues of the therapy;Primary end point(s):	—

Countries

Finland

Contacts

Public ContactNaSy

Tampere University Hospital

kati.tihtonen@pshp.fi358331165006

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026